Newshero

RECENT NEWS

For Media Inquiries

Alisa Santiesteban, Director of Marketing & Communications
970-926-1277 / Alisa@CanDo-MS.org

Media Kit



    New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

    April 26th, 2021

    New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

    Continue Reading
    Janssen Announces U.S. FDA Approval of PONVORY™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis

    March 19th, 2021

    TITUSVILLE, N.J.March 19, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.

    Continue Reading
    SKI for MS Launches Virtual Vertical Challenge to Help Families Living With MS

    January 22nd, 2021

    SKI for MS, a fundraising ski event benefiting families living with multiple sclerosis (MS), has gone virtual for the 2021 season.

    Continue Reading
    Color Street Donates $300,000 In Support of COVID-19 Response Measures

    January 13th, 2021

    To support their charity partners in the wake of the COVID-19 pandemic, and help offset the expense of measures each organization has implemented to assist their clients, Color Street is donating $10,000 to each of their 30 2018-2020 awareness campaign charity partners. 

    Continue Reading
    This September, show the world how you #ThriveWithMS to inspire others and spread awareness of multiple sclerosis

    August 28th, 2020

    Can Do Multiple Sclerosis, a non-profit that delivers health and wellness education programs for families with MS, launched their annual, online campaign today that encourages people living with MS, as well as their friends and supporters, to share how they thrive with MS during September’s Can Do Month celebration.

    Continue Reading
    Color Street Foundation pledges $100,000 to support MS awareness

    August 10th, 2020

    For the month of August, the Color Street Foundation is pledging $100,000 to support awareness, research, and direct support programs for those who live with MS. 

    Continue Reading
    Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS

    June 1st, 2020

    ROCKLAND, Mass., May 27, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced today the U.S. Food and Drug Administration (FDA) has approved the inclusion of new safety data on pregnancy and breastfeeding in the prescribing information for Rebif® (interferon beta-1a), in accordance with the FDA's Pregnancy and Lactation Labeling Rule (PLLR). 

    Continue Reading
    Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA®

    June 1st, 2020

    PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that ZEPOSIA® (ozanimod) 0.92 mg, a new once-daily oral medication for adults for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, is now commercially available in the U.S. ZEPOSIA was approved by the U.S. Food and Drug Administration (FDA) on March 25, 2020.

    Continue Reading
    New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis

    April 28th, 2020

    Post-hoc analysis from 6 years of Phase III open-label extension studies showed Ocrevus treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from interferon beta-1a two years later

    Continue Reading
    Art Alexakis Releases Poignant Music Video for Multiple Sclerosis-Inspired Song “The Hot Water Test”

    April 27th, 2020

    Art Alexakis, the charismatic frontman of multi-platinum selling rock band, Everclear, is premiering the music video for his multiple sclerosis (MS)-inspired song, “The Hot Water Test”.

    Continue Reading